China-based Enlight Medical Technologies (Shanghai) Co., Ltd is set to fully acquire Japanese firm Japan Lifeline’s (TYO: 7575) China unit Synexmed (Shenzhen) Co., Ltd for an undisclosed amount. This acquisition will enhance Enlight’s capabilities in the vascular intervention market.
About Synexmed and the Acquisition
Founded in 2005, Synexmed specializes in supplying the Japanese market with wire balloons and other vascular intervention medical products. Upon the transaction, Enlight will gain access to the inicio interventional microwire manufactured by JLL, as well as a world-class high-end balloon guide wire technology platform.
Comprehensive Strategic Partnership
In addition to the acquisition, Enlight has struck a comprehensive strategic partnership with JLL. The partnership includes commercial cooperation, with both companies distributing each other’s products in their respective markets. They will also seek regulatory filing and marketing opportunities globally and establish a joint research and development center.
Enlight’s Medical Device Platform
Enlight, a medical device platform company operating out of the United States and China, offers a modern integrated industrialization platform. Its focus includes structural heart disease, panvascular intervention, neural stimulation and brain-computer interface platforms, life science, and diagnosis, among other innovative technologies. This acquisition and partnership will further strengthen Enlight’s position in the medical device industry.-Fineline Info & Tech
